We are live on ! Find out more
LIAN

LianBio American Depositary Shares
LIAN

Delisted

LIAN was delisted on the 18th of March, 2024.

Back to rankings

29 hedge funds and large institutions have $377M invested in LianBio American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

221% more capital invested

Capital invested by funds: $118M → $377M (+$260M)

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

24% less funds holding

Funds holding: 38 → 29 (-9)

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

Holders
29
Holders Change
-9
Holders Change %
-23.68%
% of All Funds
0.42%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
8
Increased
11
Reduced
3
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$26M
2
AAA
Affinity Asset Advisors
New York
+$10.7M
3
BlackRock
BlackRock
New York
+$2M
4
AFM
Anson Funds Management
Texas
+$403K
5
TCM
Tybourne Capital Management
Hong Kong
+$328K

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.87M
2
Citigroup
Citigroup
New York
-$918K
3
Citadel Advisors
Citadel Advisors
Florida
-$757K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$573K
5
TD Asset Management
TD Asset Management
Ontario, Canada
-$532K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$19.7K +$15.1K +4,399 New
Morgan Stanley
27
Morgan Stanley
New York
$8.99K +$3.48K +1,011 +101%
HWM
28
HighMark Wealth Management
Minnesota
$447 +$344 +100 New
EC
29
EntryPoint Capital
New York
$206 +$158 +46 New
T. Rowe Price Associates
30
T. Rowe Price Associates
Maryland
– -$3.87M -2,598,766 Closed
Citigroup
31
Citigroup
New York
– -$918K -615,940 Closed
Citadel Advisors
32
Citadel Advisors
Florida
– -$757K -507,806 Closed
TD Asset Management
33
TD Asset Management
Ontario, Canada
– -$532K -357,038 Closed
LGM
34
Logos Global Management
California
– -$417K -280,000 Closed
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$200K -134,184 Closed
LCM
36
Landscape Capital Management
New Jersey
– -$196K -131,641 Closed
CIC
37
Cornercap Investment Counsel
Georgia
– -$151K -101,039 Closed
SG Americas Securities
38
SG Americas Securities
New York
– -$87K -58,541 Closed
SC
39
Shay Capital
New York
– -$54.1K -36,332 Closed
ETC
40
Exchange Traded Concepts
Oklahoma
– -$41.4K -27,778 Closed
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
– -$18.1K -12,175 Closed
HF
42
HRT Financial
New York
– -$15K -10,563 Closed
CSPIA
43
Cary Street Partners Investment Advisory
Virginia
– -$1.49K -1,000 Closed
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
– -$128 -86 Closed
1
2

LIAN Hedge Fund Activity: Q4 2023 in Review

29 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q4 2023, worth a combined $377M — up 221% from $118M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of LIAN and 8 opened new positions — a net loss of 8 holders — while 3 trimmed existing stakes and 11 added.

The largest buyer was Tang Capital Management, adding an estimated $26M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $3.87M sold.

  • 29 institutional investors held LianBio American Depositary Shares (LIAN) as of Q4 2023, down from 38 in Q3 2023.
  • Funds reported $377M of LianBio American Depositary Shares stock for Q4 2023, up 221% quarter-over-quarter.
  • 8 funds opened new LianBio American Depositary Shares positions in Q4 2023 and 16 closed out, a net change of -8 holders.
  • The largest LianBio American Depositary Shares buyer in Q4 2023 was Tang Capital Management, an estimated $26M added.
  • The largest LianBio American Depositary Shares seller in Q4 2023 was T. Rowe Price Associates, an estimated $3.87M sold.

Based on aggregated 13F filings for Q4 2023.